SCHEMBL1103041

SCHEMBL1103041

c1ccc(-c2c3ccccc3c(-c3ccc4c5c(cccc35)-c3ccccc3-4)c3cccnc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CKS1B P61024 4/20 0.37
SKP2 Q13309 4/20 0.37
GLO1 Q04760 2/20 0.37
KDM4E B2RXH2 2/20 0.35
TOP1 P11387 1/20 0.35
PIK3CD O00329 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102934 0.91 CRHBP (0.42) CRHBPCRHR2KEAP1NFE2L2KDM4E
SCHEMBL1103101 0.89 CKS1B (0.43) ENPP1CKS1BSKP2GLO1KDM4E
SCHEMBL1102984 0.86 CKS1B (0.48) ENPP1CKS1BSKP2GLO1KDM4E
SCHEMBL1103088 0.85 KDM4E (0.40) ENPP1CKS1BSKP2GLO1KDM4E
SCHEMBL1103232 0.85 ALDH1A1 (0.40) CRHBPCRHR2KEAP1NFE2L2KDM4E
SCHEMBL1102991 0.85 KDM4E (0.42) ENPP1KDM4ETOP1L3MBTL1ALDH1A1
SCHEMBL1103059 0.85 CCR1 (0.36) ENPP1CKS1BSKP2GLO1KDM4E
SCHEMBL1103173 0.84 TSHR (0.38) GLO1KDM4EL3MBTL1ALDH1A1HPGD
SCHEMBL1103069 0.83 CYP11B1 (0.53) ENPP1CKS1BSKP2GLO1KDM4E
SCHEMBL1103042 0.83 TOP1 (0.42) ENPP1CKS1BSKP2GLO1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 ENPP1 2661/4885CRHBP 4736/4885CRHR2 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.